Exploring Pharmacological Interventions for Spinal Reflex Disorders

Abstract

Spinal cord disorders show an impact on individuals motor function, resulting in a range of debilitating conditions, Offenbach, gamma amino butyric acid ( GABA ) agonist, is generally prescribed for Spinal reflex disorders namely spasticity. Tizanidine, an alpha  adrenergic agonist, shows its effects by inhibiting presynaptic motor neurons. Tizanidine assists on alleviating muscle spasticity associated with Spinal cord reflex disorders. Diazepam, a benzodiazepine,assists in decreasing muscle spasticity as well as hyoerflexia. Diazepam is frequently used as a muscle relaxant particularly in the treatment of Spinal cord reflexes. Gabapentin, has originally developed as an anti-epileptic drug, is helpful for neuropathic as well as spasticity. Gabapentin helps in managing symptoms associated with Spinal reflex disorders. Botulinum toxin is generally termed as Botox, is injected into muscles to stop the release of acetyl choline, a neuro transmitter essential for muscle contraction. Memantine, an N methyl D asparate ( NMDA ) receptor antagonst, had exhibited it's beneficial role in spasticity as well as hyper reflexia. Finally, it is concluded that pharmacological interventions for Spinal reflex disorders aim to restore balance especially in neural signalling, alleviate muscle spasticity abd increase overall motor function.